Indefinite Delivery Contract VA24912D0107

The Defense Health Agency awarded a single-award blanket purchase agreement to Hcsc Blood Center, operating as Miller-Keystone Blood Center, to supply blood products in support of healthcare programs. With a potential value of $6 million, the BPA enables ordering of blood components such as red blood cells, frozen plasma, and platelets through February 2025 at locations to be determined. No set-aside provisions were applied under the terms of this IDV, reflecting the Agency's need to fulfill...

The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) has awarded a single-award Blanket Purchase Agreement (BPA) to Zen-Bio, Inc. (doing business as Zenbio), a for-profit manufacturer of human blood products located in Durham, North Carolina. The BPA, valued at $0.00 ceiling, is for the procurement of "BPA FOR BLOOD UNITS" to support the CDC's disease monitoring, prevention, and research efforts in Pittsburgh, Pennsylvania. Under this...

This Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Immucor Inc., a manufacturer of blood banking reagents and diagnostic products. The BPA facilitates recurring purchases of Immucor's bulk blood bank reagents on an as-needed basis, as evidenced by the multiple firm-fixed price call orders issued between January 2018 and March 2020 totaling approximately $149,000. Performance takes place at Immucor's location in Norcross, Georgia. The original...

This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA) to The American National Red Cross (doing business as American Red Cross) for the provision of blood products. The BPA has a ceiling value of $15,000,000.00 and an ultimate completion date of March 31, 2029. The American Red Cross, as a major supplier of blood and blood products to the federal government, particularly the Department of Veterans Affairs (VA) and Department of Defense (DoD), will deliver a wide...

This Blanket Purchase Agreement (BPA) was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), to MBL International Corporation, a for-profit manufacturer of goods. The BPA covers the procurement of blood/blood products, biological materials, and chemicals. The BPA has no set-aside and was originally awarded on July 11, 2002, with an open-ended potential value. Under this BPA, three task orders have been issued to date. The first, awarded on...

The Defense Health Agency and U.S. Army Medical Command have awarded the Republic of Korea National Red Cross, doing business as Gyeonggi Blood Center Red Cross, a five-year, $249,000 Blanket Purchase Agreement (BPA) to provide blood products in support of U.S. military medical facilities in South Korea. This single-award IDV vehicle allows the agencies to place firm-fixed-price orders for items such as apheresis platelets, whole blood units, and other critical blood supplies on an as-needed...

The American National Red Cross, operating through its Shared Service Center Division as Red Cross, has been awarded a Blanket Purchase Agreement (BPA) contract by the Medical Command, a component of the Defense Health Agency, to provide blood products and related services. The BPA, valued at $840,000 and running through March 2023, enables the agency to efficiently order blood supplies, laboratory testing, and transfusion support as needs arise to support federal healthcare operations. Under...

The Blanket Purchase Agreement (BPA) contract HT940624A0001 was awarded by the Defense Health Agency (DHA) to the American National Red Cross, a non-profit organization and major supplier of blood products to the U.S. federal government. The contract, which has an ultimate completion date of September 30, 2029, aims to provide a reliable supply of blood products including low titer O whole blood, liquid plasma, and related testing services to support military healthcare facilities and...

The Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 (VISN 8) awarded a single-award Blanket Purchase Agreement (BPA) to The American National Red Cross (doing business as American Red Cross) for the procurement of blood products and blood components. The $4.8 million BPA has a period of performance from April 1, 2025 to March 31, 2029. The BPA allows VISN 8 and other VA entities to efficiently order blood, plasma, platelets, and related testing and laboratory...

The U.S. National Institutes of Health (NIH) Clinical Center awarded a single-award Indefinite Delivery Contract (IDC) to the American National Red Cross to procure a variety of critical blood and blood products, including red blood cells, plasma, cryoprecipitate, and apheresis platelets. The $1.86M IDC has a period of performance through March 2025 and aims to ensure a reliable supply of these essential medical commodities to support patient treatment and research activities at the NIH...